loading
전일 마감가:
$0.1172
열려 있는:
$0.0268
하루 거래량:
149.41K
Relative Volume:
66.00
시가총액:
$N/A
수익:
$9.94M
순이익/손실:
$-144.49M
주가수익비율:
-0.00594
EPS:
-5.05
순현금흐름:
$-103.90M
1주 성능:
-73.55%
1개월 성능:
-79.82%
6개월 성능:
-98.42%
1년 성능:
-99.50%
1일 변동 폭
Value
$0.0257
$0.03
1주일 범위
Value
$0.0257
$0.03
52주 변동 폭
Value
$0.0257
$0.03

Syros Pharmaceuticals Inc Stock (SYRS) Company Profile

Name
명칭
Syros Pharmaceuticals Inc
Name
전화
-
Name
주소
-
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
SYRS's Discussions on Twitter

SYRS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SYRS
Syros Pharmaceuticals Inc
0.03 0 9.94M -144.49M -103.90M -5.05
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Syros Pharmaceuticals Inc Stock (SYRS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-11-04 업그레이드 H.C. Wainwright Neutral → Buy
2020-09-22 개시 Alliance Global Partners Buy
2020-01-17 다운그레이드 Wedbush Outperform → Neutral
2019-03-08 재개 JMP Securities Mkt Outperform
2019-02-14 재개 Oppenheimer Outperform
2018-11-05 업그레이드 ROTH Capital Neutral → Buy
2018-03-13 재확인 Wedbush Outperform
2017-10-31 재개 Piper Jaffray Overweight
2017-10-23 개시 ROTH Capital Neutral
2017-08-10 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
모두보기

Syros Pharmaceuticals Inc 주식(SYRS)의 최신 뉴스

pulisher
03:52 AM

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Receives Consensus Rating of “Hold” from Analysts - Defense World

03:52 AM
pulisher
May 30, 2025

SYROS PHARMACEUTICALS Earnings Preview: Recent $SYRS Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 30, 2025
pulisher
May 16, 2025

Syros Pharmaceuticals (NASDAQ:SYRS) Now Covered by StockNews.com - Defense World

May 16, 2025
pulisher
May 12, 2025

Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight - GlobeNewswire Inc.

May 12, 2025
pulisher
May 08, 2025

Syros Pharmaceuticals (NASDAQ:SYRS) Coverage Initiated by Analysts at StockNews.com - Defense World

May 08, 2025
pulisher
May 07, 2025

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

May 07, 2025
pulisher
May 02, 2025

StockNews.com Begins Coverage on Syros Pharmaceuticals (NASDAQ:SYRS) - Defense World

May 02, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
Apr 22, 2025

StockNews.com Initiates Coverage on Syros Pharmaceuticals (NASDAQ:SYRS) - Defense World

Apr 22, 2025
pulisher
Apr 15, 2025

Rege Nephro buys Tamibarotene-related assets from Syros Pharmaceuticals - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Rege Nephro Acquires Assets from Syros Pharmaceuticals (SYRS) - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Rege Nephro Acquires Key Assets from Syros Pharmaceuticals (SYRS - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Rege Nephro Acquires Key Assets from Syros Pharmaceuticals (SYRS) | SYRS Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Major Kidney Disease Drug Acquisition: Rege Nephro Takes Over Syros' Phase 2 Asset - Stock Titan

Apr 15, 2025
pulisher
Apr 15, 2025

Rege Nephro Acquires Tamibarotene-Related Assets from Syros Phar - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials - digitalmore.co

Apr 15, 2025
pulisher
Apr 14, 2025

Syros Pharma pulls out of deal with RaQualia - The Pharma Letter

Apr 14, 2025
pulisher
Apr 14, 2025

Syros Pharmaceuticals (NASDAQ:SYRS) Coverage Initiated at StockNews.com - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Given Average Recommendation of “Hold” by Brokerages - Defense World

Apr 12, 2025
pulisher
Mar 27, 2025

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Short Interest Up 345.9% in March - Defense World

Mar 27, 2025
pulisher
Mar 21, 2025

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Receives $3.33 Average PT from Brokerages - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

Syros Pharmaceuticals (SYRS) to Release Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Dow Dips Over 200 Points; US Industrial Production Increases More than Expected - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga India

Mar 18, 2025
pulisher
Mar 17, 2025

Analyze Syros Pharmaceuticals Inc (NASDAQ: SYRS) Before Investing. - stocksregister.com

Mar 17, 2025
pulisher
Mar 14, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 14, 2025
pulisher
Mar 13, 2025

Finance Watch: Sutro Halves Workforce, Cuts Lead ADC And CEO Moves On - Citeline News & Insights

Mar 13, 2025
pulisher
Mar 12, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews

Mar 12, 2025
pulisher
Mar 11, 2025

US Stocks Mixed; Kohl's Shares Plunge After Q4 Results - Benzinga

Mar 11, 2025
pulisher
Mar 10, 2025

Aptevo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:APVO - Benzinga

Mar 10, 2025
pulisher
Mar 07, 2025

Syros Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 04, 2025

Syros Pharmaceuticals settles debt with Oxford Finance By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Syros Pharmaceuticals settles debt with Oxford Finance - Investing.com India

Mar 04, 2025
pulisher
Mar 03, 2025

Why US Stock Futures Are Rising TodayInvesco QQQ Trust, Series 1 (NASDAQ:QQQ), SPDR S&P 500 (ARCA:SPY) - Benzinga

Mar 03, 2025
pulisher
Mar 01, 2025

Syros Pharmaceuticals, Inc. Announces Cessation of Gerald Quirk as Chief Executive Officer, Effective March 01, 2025 - Marketscreener.com

Mar 01, 2025
pulisher
Mar 01, 2025

Syros Pharmaceuticals, Inc. Announces Management Changes -February 28, 2025 at 04:15 pm EST - Marketscreener.com

Mar 01, 2025
pulisher
Feb 28, 2025

Stocks to Watch: Toro, Syros Pharmaceuticals - MarketWatch

Feb 28, 2025
pulisher
Feb 28, 2025

Syros to delist from Nasdaq, deregister from SEC - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Syros Pharmaceuticals Delists from Nasdaq Amid Restructuring - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Syros Pharmaceuticals to Delist from Nasdaq, Deregister Common Shares -February 28, 2025 at 04:41 pm EST - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Syros Pharmaceuticals voluntarily delists from Nasdaq, deregisters common stock - TipRanks

Feb 28, 2025

Syros Pharmaceuticals Inc (SYRS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):